Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2021 August;112(4) > Minerva Medica 2021 August;112(4):531-3

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   

Minerva Medica 2021 August;112(4):531-3

DOI: 10.23736/S0026-4806.19.06251-7

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

MiR-338-3p inhibits growth of glioblastoma through targeting MAP4K3

Yanqun SONG 1, Fengxia ZHANG 2, Lu LI 3, Baolong SONG 4, Jiajun XU 5, 6, Guodong WANG 5, 6, Zhiming ZHENG 5, 6

1 Department of Neurosurgery, The 3rd People’s Hospital of Heze City, Heze, China; 2 Department of Anesthesiology, The 3rd People’s Hospital of Heze City, Heze, China; 3 Department of Neurosurgery, Yantai Ludong Hospital (Shandong Provincial Hospital Group), Yantai, China; 4 Department of Neurosurgery, People’s Hospital of Yuncheng County, Heze, China; 5 Department of Neurosurgery, Shandong Provincial Hospital, Jinan, China; 6 Department of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China



top of page